Welcome to IQnovate
iQnovate is a publicly listed life sciences organisation trading on the National Stock Exchange of Australia (IQN) and cross listed on the GXG Main Quote in Europe (IQN) and the OTCQB in New York (IQNDY).
The life sciences sector is one of the best performing industries globally. Through the intersection of dedicated medical and clinical research, the life sciences sector supports the development of human therapeutics, clinical diagnostics and medical devices that empower people to lead happier and healthier lives. It is made up of a diverse range of industry participants including biotechnology firms, pharmaceutical conglomerates, manufacturing companies, research organisations, state and federal government departments, academic institutions, industry bodies, healthcare organisations and medical and allied health groups within the clinical setting as well as specialist providers who deliver support functions, products and services that are essential to the functioning of the sector.
The forecast for the increasing demand in the life sciences sector is being driven by considerable macro-forces including:
A rapidly increasing global population
An aging populace
More sedentary lifestyles leading to obesity and other related health concerns including heart disease, diabetes and cancer
An increase in the incidence of both infectious and chronic diseases
Technological and medical advances
Increased wealth in the emerging world and;
Improved access to affordable healthcare in many parts of the world
Along with two wholly owned subsidiaries, FarmaForce Pty Ltd and Clnical Research Corporation Pty Ltd, iQnovate is uniquely positioned to provide integrated scientific advisory, IP asset management and contract drug development services to the global life sciences sector.
FarmaForce is a contract sales organisation
catering to the Australian Pharmaceutical
Clincal Research Corporation (CRC)is a life science organisation providing
strategic Medical Affairs, targeted Clinical
Affairs and specialist Scientific Advisory
and Due Diligence services to the
Australian biopharmaceutical sector.
The leadership team across the three organisations brings decades of drug development experience as well as proven expertise in navigating the complex hurdles faced by stakeholders on life science projects.
This presents a compelling opportunity for investors to become active in the life sciences space.
To register your interest in investing in the iQnovate philosophy, please contact us today:
Phone: +61 2 8239 5400
Level 3 & 6, 222 Clarence Street
Sydney NSW Australia 2000